Amneal Suffers Setback On US Cinacalcet

Non-Infringement Of Amgen Sensipar Formulation Patent Overturned

 
• By Aidan Fry
  
Amneal
Amneal's cinacalcet may infringe Amgen’s formulation patent • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin